Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$2.49 - $3.5 $36,983 - $51,985
14,853 Added 21218.57%
14,923 $37,000
Q3 2022

Nov 14, 2022

SELL
$2.82 - $3.58 $41,885 - $53,173
-14,853 Reduced 99.53%
70 $0
Q4 2021

Feb 11, 2022

BUY
$3.85 - $6.71 $18,476 - $32,201
4,799 Added 47.4%
14,923 $58,000
Q3 2021

Nov 04, 2021

SELL
$5.6 - $8.58 $227,360 - $348,348
-40,600 Reduced 80.04%
10,124 $57,000
Q2 2021

Aug 11, 2021

SELL
$7.16 - $9.41 $1.02 Million - $1.34 Million
-142,351 Reduced 73.73%
50,724 $436,000
Q1 2021

May 13, 2021

BUY
$7.52 - $15.55 $1.26 Million - $2.6 Million
167,051 Added 641.91%
193,075 $1.83 Million
Q4 2020

Feb 16, 2021

SELL
$5.0 - $8.85 $610,480 - $1.08 Million
-122,096 Reduced 82.43%
26,024 $180,000
Q3 2020

Nov 12, 2020

BUY
$4.96 - $7.08 $160,852 - $229,604
32,430 Added 28.03%
148,120 $742,000
Q2 2020

Aug 13, 2020

BUY
$4.84 - $8.02 $39,426 - $65,330
8,146 Added 7.57%
115,690 $695,000
Q1 2020

May 14, 2020

SELL
$4.52 - $8.55 $5,356 - $10,131
-1,185 Reduced 1.09%
107,544 $609,000
Q4 2019

Feb 14, 2020

SELL
$6.14 - $9.3 $24,418 - $36,986
-3,977 Reduced 3.53%
108,729 $831,000
Q3 2019

Nov 14, 2019

SELL
$9.05 - $16.02 $4.35 Million - $7.71 Million
-481,079 Reduced 81.02%
112,706 $1.02 Million
Q2 2019

Aug 14, 2019

BUY
$13.58 - $18.61 $6.53 Million - $8.95 Million
481,043 Added 426.68%
593,785 $9.49 Million
Q1 2019

May 15, 2019

BUY
$11.31 - $23.7 $1.27 Million - $2.66 Million
112,412 Added 34064.24%
112,742 $2.08 Million
Q4 2018

Feb 14, 2019

BUY
$6.8 - $12.88 $2,244 - $4,250
330 New
330 $3,000
Q2 2018

Aug 14, 2018

SELL
$5.52 - $7.93 $138,000 - $198,250
-25,000 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$5.51 - $10.97 $137,750 - $274,250
25,000 New
25,000 $168,000

Others Institutions Holding CRON

About Cronos Group Inc.


  • Ticker CRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 377,896,000
  • Market Cap $778M
  • Description
  • Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of...
More about CRON
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.